Aspira Pathlab & Diagnostics Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 34.08 million compared to INR 54.39 million a year ago. Revenue was INR 34.81 million compared to INR 54.77 million a year ago. Net loss was INR 2.59 million compared to net income of INR 14.43 million a year ago. Basic loss per share from continuing operations was INR 0.25 compared to basic earnings per share from continuing operations of INR 1.52 a year ago. Diluted loss per share from continuing operations was INR 0.25 compared to diluted earnings per share from continuing operations of INR 1.52 a year ago.
For the full year, sales was INR 144.57 million compared to INR 195.42 million a year ago. Revenue was INR 147.78 million compared to INR 196.45 million a year ago. Net loss was INR 0.887 million compared to net income of INR 44.59 million a year ago. Basic loss per share from continuing operations was INR 0.09 compared to basic earnings per share from continuing operations of INR 4.33 a year ago. Diluted loss per share from continuing operations was INR 0.09 compared to diluted earnings per share from continuing operations of INR 4.33 a year ago.